About Cellmic
Cellmic is a company based in Los Angeles (United States) founded in 2009 was acquired by NOWDiagnostics in July 2018. Cellmic has raised $5 million across 6 funding rounds from investors including UCLA, HHS and NOWDiagnostics. Cellmic operates in a competitive market with competitors including Daxor, Epocal, Hemcheck, Essenlix and Chipcare, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
UCLA
& 4 more
-
Employee Count
Not available
-
Acquired by
NOWDiagnostics
(Jul 12, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cellmic
Cellmic has successfully raised a total of $5M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellmic
Cellmic has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include UCLA, HHS and NOWDiagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A challenge by XPRIZE Foundation for health sensing innovation is organized.
|
Locked | Locked | Locked | |
|
Research in biomedical imaging and bioengineering is conducted by NIBIB.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Cellmic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellmic
Investment portfolio details for Cellmic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellmic
Detailed financials for Cellmic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellmic Comparisons
Peer comparison for Cellmic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellmic
Cellmic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daxor, Epocal, Hemcheck, Essenlix and Chipcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Blood volume analyzers are developed by Daxor for diagnostic applications.
|
|
| Locked | Locked | Locked |
Biochips and solid-state diagnostic devices for blood testing are developed.
|
|
| Locked | Locked | Locked |
Devices for detecting hemolyzed blood samples are provided by Hemcheck.
|
|
| Locked | Locked | Locked |
Mobile health self-test platform is provided using nanotechnology and AI.
|
|
| Locked | Locked | Locked |
Develops a hand-held blood test device from a single drop of blood.
|
Detailed competitors of Cellmic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellmic
Complete news archive for Cellmic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellmic
Cellmic was founded in 2009.
Cellmic is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Cellmic is a funded company, having raised a total of $5M across 6 funding rounds to date.
Cellmic was founded in 2009 in Los Angeles, United States, and operates in the medical diagnostics sector. Readers for rapid diagnostic tests are produced, including chromatographic and fluorescent versions with integrated smartphones for secure cloud-based data collection. A lens-free holographic microscope and handheld analyzers for blood count, allergens, and mercury contamination are under development. Recognition has been received through awards such as Technology Pioneer 2015 by the World Economic Forum.
Cellmic's top competitors include Daxor, Pathshodh Healthcare and Hemcheck.
Cellmic has 5 investors. Key investors include UCLA, HHS, NOWDiagnostics, Nokia Sensing XCHALLENGE, and National Institute of Biomedical Imaging and Bioengineering.